Clinical Trial Services Company VeraSci Joins Forces with ActiGraph to Expand Wearables Use in Clinical Trials

VeraSci ActiGraph partnership

VeraSci, a global clinical research company announced it has partnered with ActiGraph, a leading provider of medical-grade wearable activity and sleep monitoring devices. VeraSci’s Innovation Lab will be incorporating ActiGraph’s CentrePoint Insight Watch into an NIH-funded study examining the relationship between real-time measurements of gait and actigraphy collected by industry-grade wearables and established cognitive and functional endpoints that are sensitive to decline early in the Alzheimer’s disease continuum.

Read more Koneksa Publishes Data Assessing Wearable Devices for Clinical Trial Participants

Preliminary data have indicated a correlation between remotely captured gait and actigraphy measures and established cognition and function measures. These data suggest that wearables can provide meaningful information regarding cognitive health and may ultimately contribute to continuous assessment of cognition and function in clinical trials, says a press release.

“Wearables present an incredible opportunity to gather data in ways that haven’t been feasible before. We can gather information directly while patients are engaged in their daily lives,” says VeraSci CEO Dr. Rich Keefe, “Our partnership with ActiGraph advances our commitment to pairing scientific knowledge with cutting-edge technology to improve the tools and measurements available in clinical trials.”

“This partnership between ActiGraph and VeraSci provides an exciting opportunity to better understand the relationship between real-world physical behavior, function, and cognition,” said Matt Biggs, ActiGraph’s Head of Business Operations. “We believe that these types of collaborations will help to jumpstart the creation of novel digital endpoints for global health communities.”

VeraSci ActiGraph partnership

The research was supported by the National Institute on Aging of the National Institutes of Health Small Business Innovation Research (SBIR) program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Read more Spark Biomedical Launches Clinical Trial to Validate its Auricular Neurostimulation Device for Opioid Withdrawal Relief

About VeraSci

VeraSci brings scientific expertise, strategic innovation, and unwavering commitment to each project, helping clients worldwide develop novel therapies.

About ActiGraph

ActiGraph’s FDA-cleared wearable actigraphy monitors and robust analytics platform have been widely used to quantify human movement in academic and population health research for nearly two decades. In recent years, the company’s monitoring solutions have been steadily adopted by pharmaceutical and life sciences organizations seeking to capture real-world objective outcomes related to physical activity, mobility, and sleep behavior for patients enrolled in clinical trials.

Previous articleMediaTek Launches New Dimensity 5G Smartphone Chipsets with Unrivaled AI and Multimedia
Next articleValencell Launches Software Library, Helping Manufacturers to Integrate the Company’s Software Into Their Wearables
Cathy Russey
Cathy Russey () is Online Editor at WT | Wearable Technologies and specialized in writing about the latest medical wearables and enabling technologies on the market. Cathy can be contacted at info(at)